Arcturus Therapeutics Holdings Inc. - COM (ARCT)

Historical Portfolio Holders from Q2 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
26.3M
Holdings value Q2 2024
$640M
Value change Q2 2024
-$34.9M
Grand Portfolio weight change Q2 2024
0%
Number of holders
168
Number of buys Q2 2024
28
Number of sells Q2 2024
-19
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 8.66M $201M +$34.6M $23.21 59
2024 Q2 26.3M $640M -$34.9M $24.35 169
2024 Q1 27.2M $918M +$63M $33.77 179
2023 Q4 25.4M $802M +$9.91M $31.53 167
2023 Q3 25.2M $643M +$38.2M $25.55 147
2023 Q2 23.6M $678M +$11.5M $28.68 143
2023 Q1 23.3M $558M +$17.2M $23.97 125
2022 Q4 22.6M $384M +$11.5M $16.96 111
2022 Q3 22.2M $328M -$1.83M $14.82 106
2022 Q2 20.6M $334M +$9.25M $15.74 117
2022 Q1 21.5M $578M +$37.2M $26.96 124
2021 Q4 19.9M $736M +$29.4M $37.01 134
2021 Q3 19.1M $909M -$50.3M $47.78 150
2021 Q2 20.5M $694M +$36.7M $33.84 133
2021 Q1 18.8M $776M -$48.9M $41.30 152
2020 Q4 19.9M $864M +$70.1M $43.38 132
2020 Q3 18.2M $783M +$222M $42.90 127
2020 Q2 12.9M $606M +$389M $46.74 112
2020 Q1 4.74M $65.7M +$2.32M $13.59 54
2019 Q4 4.55M $50.1M -$173K $10.87 50
2019 Q3 4.61M $47.3M +$27.9M $10.27 39
2019 Q2 1.88M $17.7M +$17.7M $9.44 20